The 2024 Academy of Managed Care Pharmacy (AMCP) Nexus conference from Oct. 14–17 gathers more than 2,500 managed care leaders to Las Vegas, Nevada, to discuss some of the most complex issues facing the health care industry. Here is a roundup of Prime's award-winning presentations, research, insights and perspectives from the event. This will be refreshed regularly to include the latest updates from the event. 

Event  

Prime presents at AMCP Nexus 2024 on Oct. 14–17
Annual conference gathers 2,500+ managed care leaders to discuss complex health care issues.
Read more »
 

Press release

Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024
Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more
Read more »
 

Perspectives

A preview of Prime Therapeutics’ presence at AMCP Nexus 2024
Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this week
Read more »

AMCP Nexus 2024 in focus: Research shows translation services improve health equity for Medicare members 
Nicole Gevenitz, director of clinical account services, shares more from the research study “Promoting Health Equity Through Enhanced, Personalized Digital Outreach” 
Read more »

AMCP Nexus in focus: New research offers insight into use of faricimab-svoa (Vabysmo^®) therapy for retinal diseases
Lead author David Eckwright shares more about the study “Real-World Extended Dosing Assessment for Eye(s) New to Faricimab-svoa Therapy” 
Read more »

AMCP Nexus 2024 in focus: How Prime’s utilization management strategies improve cost savings for immunoglobulin replacement therapy 
Lead authors Erin Ventura and Alina Liang share more about the study “Evaluating the 10-Year Impact of an Immunoglobulin Utilization Management and Dose Optimization Program in the Managed Care Setting”
Read more »

AMCP Nexus 2024 in focus: Research details impact of gene therapy treatment for spinal muscular atrophy
Scott Leslie, director of health outcomes, shares more about the study “Real-World Case Series Study of Spinal Muscular Atrophy Pediatric Patients Treated With Onasemnogene Abeparvovec (Zolgensma)”
Read more »

AMCP Nexus 2024 in focus: How social determinants of health data can be used to better treat patients with diabetes
Jared Scripture, health outcomes scientist, shares more about the study “Leveraging Publicly Available SDOH Measures to Segment Members and Quantify Differences in Diabetic Medication Adherence: A Latent Profile Analysis”
Read more »

AMCP Nexus 2024 in focus: Student session seeks to decode cell and gene therapy
Prime experts present “A beginner’s guide to decoding cell and gene therapy” educational session at event in Las Vegas, Nevada
Read more »

AMCP Nexus 2024 in focus: Strategies for managing complex eye conditions
Experts share insights in “The evolving strategies for managing nAMD and DME” session at Las Vegas event
Read more »

AMCP Nexus 2024 in focus: Experts share how to improve Medicare Star measures using real-world insights
Prime’s Sean Wuest and Highmark Health’s Lisanne Holley present educational session at Las Vegas event
Read more »

AMCP Nexus 2024 in focus: Exploring drug cost savings through HighTouchRx^®
Nick Friedlander, clinical program pharmacist at Prime, shares more about two research studies that convey the impact of one cost-savings solution
Read more »

In the news

Coming soon